v3.26.1
Consolidated Statements of Comprehensive Loss - USD ($)
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Income Statement [Abstract]    
Net loss $ (20,643,455) $ (8,707,226)
Other comprehensive income (loss)    
Foreign currency translation adjustments (2,760) (9,845)
Comprehensive loss (20,646,215) (8,717,071)
Less comprehensive loss attributed to non-controlling interest (1,542) (1,081)
Comprehensive loss attributable to Mangoceuticals, Inc. stockholders $ (20,644,673) $ (8,715,990)